21st Austria weekly - Valneva (07/08/2025)

Valneva: Austrian/French Valneva SE, a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ^® in individuals 60 years of age and older and has approved updates to the Prescribing Information (PI) for IXCHIQ^®. IXCHIQ^® remains indicated in the United States for the prevention of disease caused by the Chikungunya Virus (CHIKV) in individuals 18 years of age and older who are at high risk of exposure to CHIKV. The FDA decision follows the announcement in July by the European Medicines Agency (EMA)¹ which recommended the lifting of temporary restrictions in elderly people after the conclusion of a thorough review of IXCHIQ^® by its safety committee (PRAC).
Valneva: weekly performance: 21.47%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (07/08/2025)

Christian Drastil: Wiener Börse Plausch

Börsepeople im Podcast S22/18: Christian Mattasits

Bildnachweis

1. Valneva - Valneva Has a Specialist Travel Vaccine Business and is a Contractor to the US Military   >> Öffnen auf photaq.com

Aktien auf dem Radar:VIG, Kapsch TrafficCom, UBM, EuroTeleSites AG, Flughafen Wien, Palfinger, ATX, ATX Prime, ATX TR, ATX NTR, Bawag, Andritz, Mayr-Melnhof, Telekom Austria, RBI, voestalpine, SBO, Frequentis, Pierer Mobility, BKS Bank Stamm, Oberbank AG Stamm, Warimpex, Amag, EVN, CPI Europe AG, Lenzing, Österreichische Post, RHI Magnesita, Deutsche Telekom, Allianz, Fresenius.

Random Partner

---

Palfinger
Palfinger zählt zu den international führenden Herstellern innovativer Hebe-Lösungen, die auf Nutzfahrzeugen und im maritimen Bereich zum Einsatz kommen. Der Konzern verfügt über 5.000 Vertriebs- und Servicestützpunkte in über 130 Ländern in Europa, Nord- und Südamerika sowie Asien.

>> Besuchen Sie 62 weitere Partner auf boerse-social.com/partner